The European Sold Production of Blood-Grouping Reagents in 2023 saw Germany leading with 761.25 million euros, followed by Hungary and Italy with significantly lower values. Germany exhibited a notable year-on-year growth of 6.57%, highlighting its strong market position. Hungary experienced a modest increase of 1.96%, while Denmark and Croatia showed minimal variation, indicating market stability in these countries.
Future trends to watch include the potential for technological advancements in blood-testing processes, regulatory changes affecting production standards, and increasing demand for precision in diagnostics, which could drive growth in countries currently showing smaller production values. Monitoring these factors will be crucial for understanding market dynamics.
Top countries in Sold Production of Blood-Grouping Reagents by Country
| # | 5 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 761,250,000 | 2023 | +1.75% | +6.57% | View data |
| 2 | 2 Hungary | 5,292,600 | 2023 | -0.26% | +1.96% | View data |
| 3 | 3 Italy | 1,176,000 | 2021 | View data | ||
| 4 | 4 Denmark | 363,370 | 2023 | +3.14% | View data | |
| 5 | 5 Croatia | 198,320 | 2023 | -1.17% | +0.59% | View data |
